Veale D J, Ritchlin C, FitzGerald O
Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii26-9. doi: 10.1136/ard.2004.031740.
Psoriatic arthritis (PsA) is characterised by several unique clinical features that differentiate it from rheumatoid arthritis (RA). Attempts to identify immunopathological mechanisms, some shared with psoriasis, that underlie these differences from RA have been most challenging. Recent research studies, however, highlight novel findings in PsA at the molecular, cellular, and tissue levels that form the basis for a new understanding of this relatively common form of inflammatory arthritis. In particular, the availability of new, biological antitumour necrosis factor alpha therapies have allowed further insight into the immunopathology of psoriasis and PsA. This brief review focuses on immunohistological studies in psoriatic skin, PsA synovium, and bone to demonstrate how these data advance our knowledge of disease pathogenesis.
银屑病关节炎(PsA)具有若干独特的临床特征,使其有别于类风湿关节炎(RA)。试图确定与银屑病共有的、构成这些与RA差异基础的免疫病理机制极具挑战性。然而,最近的研究突出了PsA在分子、细胞和组织水平的新发现,这些发现为重新认识这种相对常见的炎性关节炎奠定了基础。特别是,新型生物抗肿瘤坏死因子α疗法的出现使人们对银屑病和PsA的免疫病理学有了更深入的了解。本简要综述重点关注银屑病皮肤、PsA滑膜和骨骼的免疫组织学研究,以展示这些数据如何推动我们对疾病发病机制的认识。